*University of Washington School of Medicine

‡Clinical Research Division, Fred Hutchinson Cancer Center

§Division of Medical Oncology

∥Division of Hematology, University of Washington

#Department of Radiation Oncology

†Department of Radiology, University of Washington, Seattle, WA

¶Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

No author received any source of funding or support for this work. A.J.C.: Research funding: Janssen, Abbvie, Bristol Myers Squibb, Adaptive, Sanofi, Nektar, Harpoon. Consultancy: Janssen, Abbvie, BMS, Sanofi, Secura Bio, Celgene, GSK, EUSA, Allogene. L.A.H.: Research funding: Seattle Genetics, Sanofi, Millennium Takada, Bristol Myers Squibb, Merck, Janssen. Royalty: Up-To-Date. The remaining authors declare no conflicts of interest.

Correspondence: Yolanda D. Tseng, MD, MPhil, Department of Radiation Oncology, University of Washington, 1959 NE Pacific Street, Box 356043, Seattle, WA 98195. E-mail: [email protected].

Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.amjclinicaloncology.com.